Literature DB >> 19435751

Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.

L K Fisniku1, D R Altmann, M Cercignani, D J Tozer, D T Chard, J S Jackson, K A Miszkiel, K Schmierer, A J Thompson, D H Miller.   

Abstract

BACKGROUND: In multiple sclerosis, grey matter (GM) damage appears more clinically relevant than either white matter damage or lesion load.
OBJECTIVE: We investigated if normal-appearing white matter (NAWM) and grey matter tissue changes assessed by magnetization transfer ratio were associated with long-term disability.
METHODS: Sixty-nine people were assessed 20 years after presentation with a clinically isolated syndrome (CIS) [28 still CIS, 31 relapsing-remitting multiple sclerosis, 10 secondary progressive multiple sclerosis], along with 19 healthy subjects. Mean magnetization transfer ratio, peak height (PH) and peak location of the normalized magnetization transfer ratio histograms were determined in NAWM and grey matter, as well as, white matter and GM Fraction (GMF) and T(2)-weighted lesion load.
RESULTS: Median expanded disability status scale for multiple sclerosis patients was 2.5 (range 1-8). GM-PH, and less so, NAWM mean and peak location, were lower in multiple sclerosis patients (P = 0.009) versus controls, relapsing-remitting multiple sclerosis versus CIS (P = 0.008) and secondary progressive multiple sclerosis versus relapsing-remitting multiple sclerosis (P = 0.002). GM-PH (as well as GMF) correlated with expanded disability status scale (r(s) = -0.49; P = 0.001) and multiple sclerosis functional score (r(s) = 0.51; P = 0.001). GM-PH independently predicted disability with similar strength to the associations of GMF with clinical measures.
CONCLUSION: Grey matter damage was related to long-term disability in multiple sclerosis cohort with a relatively low median expanded disability status scale. Markers of intrinsic grey matter damage (magnetization transfer ratio) and tissue loss offer clinically relevant information in multiple sclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19435751      PMCID: PMC3040974          DOI: 10.1177/1352458509103715

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  49 in total

1.  Thalamic neurodegeneration in multiple sclerosis.

Authors:  Alberto Cifelli; Marzena Arridge; Peter Jezzard; Margaret M Esiri; Jacqueline Palace; Paul M Matthews
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

Review 2.  Magnetization transfer histogram methodology: its clinical and neuropsychological correlates.

Authors:  M A van Buchem; J C McGowan; R I Grossman
Journal:  Neurology       Date:  1999       Impact factor: 9.910

3.  Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

Authors:  Federica Agosta; Marco Rovaris; Elisabetta Pagani; Maria Pia Sormani; Giancarlo Comi; Massimo Filippi
Journal:  Brain       Date:  2006-09-02       Impact factor: 13.501

4.  Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.

Authors:  Marco Rovaris; Elda Judica; Jaume Sastre-Garriga; Alex Rovira; Maria Pia Sormani; Beatrice Benedetti; Tijmen Korteweg; Nicola De Stefano; Zhaleh Khaleeli; Xavier Montalban; Frederik Barkhof; David H Miller; Chris Polman; Alan J Thompson; Massimo Filippi
Journal:  Mult Scler       Date:  2008-01-21       Impact factor: 6.312

5.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.

Authors:  L K Fisniku; P A Brex; D R Altmann; K A Miszkiel; C E Benton; R Lanyon; A J Thompson; D H Miller
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

6.  Cortical demyelination in PML and MS: Similarities and differences.

Authors:  N M Moll; A M Rietsch; A J Ransohoff; M B Cossoy; D Huang; F S Eichler; B D Trapp; Richard M Ransohoff
Journal:  Neurology       Date:  2008-01-29       Impact factor: 9.910

7.  Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

Authors:  A Carlos Santos; Sridar Narayanan; Nicola de Stefano; M Carmela Tartaglia; Simon J Francis; Rozie Arnaoutelis; Zografos Caramanos; Jack P Antel; G Bruce Pike; Douglas L Arnold
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

8.  Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis.

Authors:  M D Phillips; R I Grossman; Y Miki; L Wei; D L Kolson; M A van Buchem; M Polansky; J C McGowan; J K Udupa
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

9.  Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.

Authors:  G R Davies; D R Altmann; A Hadjiprocopis; W Rashid; D T Chard; C M Griffin; P S Tofts; G J Barker; R Kapoor; A J Thompson; D H Miller
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

10.  Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

Authors:  Ian M Pomeroy; Elaine K Jordan; Joseph A Frank; Paul M Matthews; Margaret M Esiri
Journal:  Neurosci Lett       Date:  2008-03-28       Impact factor: 3.046

View more
  17 in total

1.  Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.

Authors:  Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501

2.  Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Authors:  Wallace J Brownlee; Bhavana Solanky; Ferran Prados; Marios Yiannakas; Patricia Da Mota; Frank Riemer; Manuel Jorge Cardoso; Sebastian Ourselin; Xavier Golay; Claudia Gandini Wheeler-Kingshott; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-04       Impact factor: 10.154

3.  Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination.

Authors:  Mishkin Derakhshan; Zografos Caramanos; Sridar Narayanan; Douglas L Arnold; D Louis Collins
Journal:  Hum Brain Mapp       Date:  2013-12-04       Impact factor: 5.038

Review 4.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 5.  The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Authors:  Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

Review 6.  New and emerging immune-targeted drugs for the treatment of multiple sclerosis.

Authors:  Alan M Palmer
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

7.  Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2011-09-09       Impact factor: 4.849

8.  Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Authors:  N Bergsland; D Horakova; M G Dwyer; O Dolezal; Z K Seidl; M Vaneckova; J Krasensky; E Havrdova; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

9.  Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.

Authors:  Stefano Magon; M Mallar Chakravarty; Michael Amann; Katrin Weier; Yvonne Naegelin; Michaela Andelova; Ernst-Wilhelm Radue; Christoph Stippich; Jason P Lerch; Ludwig Kappos; Till Sprenger
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

10.  Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.

Authors:  Vasily L Yarnykh; James D Bowen; Alexey Samsonov; Pavle Repovic; Angeli Mayadev; Peiqing Qian; Beena Gangadharan; Bart P Keogh; Kenneth R Maravilla; Lily K Jung Henson
Journal:  Radiology       Date:  2014-09-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.